Depression, cognition, and anxiety among postmenopausal women with breast cancer

Psychiatric Services

Volumn 56, Issue 11, 2005, Pages 1353-1355

  Monti, Daniel A ^a   Mago, Rajnish ^b   Shakin Kunkel, Elisabeth J ^c  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b Department of Psychiatry and Human Behavior ^*

^c THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; AMITRIPTYLINE; ANTIDEPRESSANT AGENT; GESTAGEN; MEGESTROL ACETATE; OMEGA 3 FATTY ACID; PAROXETINE; PLACEBO;

ADULT; AGED; ANXIETY; BREAST CANCER; CANCER PATIENT; CANCER RECURRENCE; COGNITION; COMORBIDITY; DEPRESSION; EXPERIENCE; FEMALE; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MASTECTOMY; MENTAL STRESS; PARTIAL MASTECTOMY; POSTMENOPAUSE; PREVALENCE; PSYCHOTHERAPY; QUALITY OF LIFE; REVIEW; SURVIVAL TIME; ARTICLE; BREAST TUMOR; GERIATRICS; PSYCHOLOGICAL ASPECT; UNITED STATES;

BREAST NEOPLASMS; COGNITION; DEPRESSION; GERIATRICS; HUMANS; POSTMENOPAUSE; UNITED STATES;

EID: 27644498116     PISSN: 10752730     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.ps.56.11.1353     Document Type: Review

References (22)

1. Cancer Facts and Figures 2004. Atlanta, American Cancer Society, 2004
2. Extermann M: Management issues for elderly patients with breast cancer. Current Treatment Options in Oncology 5:161-169, 2004
3. Maraste R, Brandt L, Olsson H, et al: Anxiety and depression in breast cancer patients at start of adjuvant radiotherapy: relations to age and type of surgery. Acta Oncologica 31:641-633, 1992
4. Sachs G, Rasoul-Rockenschaub S, Aschauer H, et al: Lytic effector cell activity and major depressive disorder in patients with breast cancer: a prospective study. Journal of Neuroimmunology 59:83-89, 1995
5. Okamura H, Watanabe T, Narabayashi M, et al: Psychological distress following first recurrence of disease in patients with breast cancer: prevalence and risk factors. Breast Cancer Research and Treatment 61:131-137, 2000
6. Koopman C, Butler LD, Classen C, et al: Traumatic stress symptoms among women with recently diagnosed primary breast cancer. Journal of Traumatic Stress 15:277-287, 2002
7. Couzi RJ, Helzlsouer KJ, Fetting JF: Prevalence of menopausal symptoms among women with a history of breast cancer and attitudes toward estrogen replacement therapy. Journal of Clinical Oncology 13:2737-2744, 1995
8. Duffy LS, Greenberg DB, Younger J, et al: Iatrogenic acute estrogen deficiency and psychiatric syndromes in breast cancer patients. Psychosomatics 40:304-308, 1999
9. Day R, Ganz PA, Costantino JP, et al: Health-related quality of life and tamoxifen in breast cancer prevention: a report from the National Surgical Adjuvant Breast and Bowel Project P-1 Study. Journal of Clinical Oncology 17:2659-2669, 1999
10. Rijken M, de Kruif AT, Komproe IH, et al: Depressive symptomatology of postmenopausal breast cancer patients: a comparison of women recently treated by mastectomy or by breast-conserving therapy. European Journal of Surgical Oncology 21:498-503, 1995
11. Ll. Rowland JH, Massie MJ: Breast cancer, in Psychooncology. Edited by Holland JC, Briebart W, Jacobsen PB, et al. New York, Oxford University Press, 1998
12. Minisini A, Atalay G, Bottomley A: What is the effect of systemic anticancer treatment on cognitive function? Lancet Oncology 5:273-282, 2004
13. Ahles TA, Saykin AJ, Furstenberg CT, et al: Neuropsychological impact of standard-dose systemic chemotherapy in long-term survivors of breast cancer and lymphoma. Journal of Clinical Oncology 20:485-493, 2002
14. Rabinowitz B: Psychosocial issues in breast cancer. Obstetrics and Gynecology Clinics of North America 29:233-247, 2002
15. Stewart DE, Cheung AM, Duff S, et al: Attributions of cause and recurrence in long-term breast cancer survivors. Psychooncology 10:179-183, 2001
16. Northouse LL, Mood D, Kershaw T, et al: Quality of life of women with recurrent breast cancer and their family members. Journal of Clinical Oncology 20:4050-4064, 2002
17. Pezzella G, Moslinger-Gehmayr R, Contu A: Treatment of depression in patients with breast cancer: a comparison between paroxetine and amitriptyline. Breast Cancer Research and Treatment 70:1-10, 2001
18. Stein KD, Jacobson PB, Hann DM, et al: Impact of hot flashes on quality of life among postmenopausal women being treated for breast cancer. Journal of Pain and Symptom Management 19:436-445, 2000
19. Spiegel D, Bloom JR, Kraemer HC, et al: Effect of psychosocial treatment on survival of patients with metastatic breast cancer. Lancet 2:888-891, 1989
20. Goodwin PJ, Leszcz MD: The effect of group psychosocial support on survival in metastatic breast cancer. New England Journal of Medicine 345:1719-1726, 2001
21. Carlson LE, Speca M, Patel KD, et al: Mindfulness-based stress reduction in relation to quality of life, mood, symptoms of stress, and levels of cortisol, dehydroepiandrosterone sulfate (DHEAS) and melatonin in breast and prostate cancer outpatients. Psychoneuroendocrinology 29:448-474, 2004
22. Monti DA, Peterson C, Kunkel EJ, et al: A randomized, controlled trial of mindfulness-based art therapy (MBAT) for women with cancer. Psycho-Oncology 14:1-11, 2005